OHRP - OHR Pharmaceutical, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue9/30/20179/30/20169/30/20159/30/2014
Total Revenue----
Cost of Revenue----
Gross Profit----
Operating Expenses
Research Development17,406.86916,460.7148,777.5194,369.413
Selling General and Administrative5,278.2727,656.3277,509.6014,287.205
Non Recurring----
Others----
Total Operating Expenses23,850.8325,306.31717,466.3749,122.924
Operating Income or Loss-23,850.83-25,306.317-17,466.374-9,122.924
Income from Continuing Operations
Total Other Income/Expenses Net39.834-459.8812,268.509-7.74
Earnings Before Interest and Taxes-23,850.83-25,306.317-17,466.374-9,122.924
Interest Expense-29.574-29.574-5.977-5.576
Income Before Tax-23,810.996-25,766.198-15,197.865-9,130.664
Income Tax Expense----
Minority Interest----
Net Income From Continuing Ops-23,810.996-25,766.198-15,197.865-9,130.664
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-23,810.996-25,766.198-15,197.865-9,130.664
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-23,810.996-25,766.198-15,197.865-9,130.664